JUN 01, 2017 4:21 PM PDT

A New Test to Measure if HIV Can Be "Cured"

WRITTEN BY: Kara Marker

When is someone “cured” of HIV? If there is such a state reachable with drug therapies, how can a doctor tell? The problem stems from HIV’s tendency to hide dormant inside of immune cells - CD4+ T cells specifically - that make remaining viruses leftover after antiviral treatment difficult to detect.

 

Dr. Anwesha Sanyal indicates HIV-infected cells collecting at the bottom of a vial being prepared for Pitt Public Health's TZA test. Credit: Tim Betler/UPMC

 

From the University of Pittsburgh Schools of the Health Sciences, researchers have published a new study in the journal Nature Medicine describing their new test design for detecting dormant HIV.

 

"Globally there are substantial efforts to cure people of HIV by finding ways to eradicate this latent reservoir of virus that stubbornly persists in patients, despite our best therapies," said senior author Phalguni Gupta, PhD. "But those efforts aren't going to progress if we don't have tests that are sensitive and practical enough to tell doctors if someone is truly cured."

 

The existing test most experts rely on is the “quantitative viral outgrowth assay” or “Q-VOA.” Its shortcomings? Q-VOA requires a large volume of blood, is labor-intensive, time-consuming, and expensive, and the estimate the test provides usually doesn’t tell the whole story.

 

The Pittsburgh researchers instead offer the new “TZA” test to detect dormant HIV, which improves upon virtually all of Q-VOA’s weaknesses. The test works by detecting activity of a unique gene that is only expressed when HIV is currently replicating. TZA produces results in one week - Q-VOA takes two - and is one-third of the cost of Q-VOA. TZA also requires a much smaller amount of blood for testing and is less labor-intensive.

Thanks to the new test, the Pittsburgh researchers discovered that the amount of dormant HIV existing in “nearly cured” people is 70 times as much as experts previously thought.

"Using this test, we demonstrated that asymptomatic patients on antiretroviral therapy carry a much larger HIV reservoir than previous estimates--as much as 70 times what the Q-VOA test was detecting," Gupta explained. "Because these tests have different ways to measure HIV that is capable of replicating, it is likely beneficial to have both available as scientists strive toward a cure."

 

The new TZA test could soon be the most commonly-used test to detect specific numbers of latent HIV in the body. With these measurements made, doctors can alter an HIV patient’s treatment plan to send them on a better, more specialized path to a true “cure.”

 

Source: University of Pittsburgh Schools of the Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 02, 2021
Microbiology
Antibodies Seem to Keep Gut Fungi in Check, Except in Crohn's Patients
DEC 02, 2021
Antibodies Seem to Keep Gut Fungi in Check, Except in Crohn's Patients
The bacteria that live in the gut microbiome have gotten a lot of attention, and for good reason; gut bacteria have been ...
DEC 09, 2021
Cancer
Inflammation: Naughty or Nice List?
DEC 09, 2021
Inflammation: Naughty or Nice List?
Aulus Cornelius Celsus, a Roman physician, first identified the four major characteristics of inflammation in the first ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
Loading Comments...